Clinical Trial Update: Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating immunotherapy in combination with prednisone and sirolimus for kidney transplant recipients with unresectable or metastatic skin canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Cell Carcinoma
• Cutaneous Melanoma
• Merkel Cell Carcinoma
• Squamous Cell Carcinoma of the Skin

Drugs mentioned

• PREDNISONE (Prednisone)
• Sirolimus (Sirolimus)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8 | Phase 1, Phase 2 | Status: RECRUITING